Mode
Text Size
Log in / Sign up
N/A N=533 Randomized Single-blind Prevention

A Digital Intervention to Prevent the Initiation of Opioid Misuse in Adolescents in School-based Health Centers

Opioid Misuse

Enrolled (actual)
533
Serious AEs
0.0%
Results posted
Apr 2026
Primary outcome: Primary: Percentage Reporting 'Great Perceived Risk of Harm' From Opioid Misuse — 66; 53 Participants

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
PlaySmart (Behavioral); Video Game Control (Other)
Age
Pediatric, Adult · 16+ yrs
Sex
All
Sponsor
Trustees of Dartmouth College
Primary completion
Mar 2025

Outcome Measures

OutcomeResultp-value
PRIMARY
Percentage Reporting 'Great Perceived Risk of Harm' From Opioid Misuse
66; 53
SECONDARY
Intentions to Misuse Opioids (p2P Lab Questions)
2.7; 2.6; 2.6; 2.7; 2.5; 2.5
SECONDARY
Self Efficacy for Refusing Opioids (p2P Lab Questions)
9.2; 9.3; 9.1; 9.1; 9.1; 9.3
SECONDARY
Knowledge About Opioid Misuse and Its Risks (p2P Lab Questions)
24.4; 24.8; 26.6; 24.4; 26.4; 24.9
SECONDARY
Positive Attitudes Toward Opioid Misuse (p2P Lab Questions)
10.3; 10.9; 10.1; 10.3; 9.7; 10.6
SECONDARY
Negative Attitudes Toward Opioid Misuse (p2P Lab Questions)
16.5; 17.7; 18.7; 17.8; 18.7; 18.8

Summary

The primary hypothesis of this study is that at 3 months, there will be a higher proportion of intervention participants vs. control participants who report greater risk of harm from misuse of prescription opioids AND heroin.

Eligibility Criteria

Inclusion Criteria

  • Participants must:
  • 1) preferably be enrolled in their high school's School-Based Health Center;
  • 2) report NOT having engaged in any prior opioid misuse;
  • 3) be at "high-risk" based on their report at baseline of past 30-day use of cigarettes, e-cigarettes, Juul, alcohol, marijuana (including synthetics), amphetamine, cocaine, benzodiazepines, ecstasy, bath salts, or any other misuse of non-opioid prescription drugs or use of non-opioid illicit drugs OR have a score of ≥1 on the PHQ-2 OR a score of ≥1 on the GAD-2 (both screening tools used by SBHA);
  • 4) be willing to sit for 60 minutes/session to play the game;
  • 5) be able to provide assent/parental/guardian consent (if under age 18).

Exclusion Criteria

  • Failure to meet any of the inclusion criteria.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT04941950). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search